Insulinomatosis: new aspects
Endocrine-Related Cancer · 23.03.2023 · 30 (6)
DOI: 10.1530/erc-22-0327 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, erschienen am 23.03.2023. Verfasst von Emanuel Christ und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetology and Metabolism and Center of Endocrine Tumors, University Hospital of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Insulinoma, Hypoglycemia, Multiple Endocrine Neoplasia Type 1, Diabetes Mellitus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Endogenous hyperinsulinemic hypoglycemia (EHH) is a rare condition with an incidence of approximately 4–6 per million person-years and comprises a group of disorders causing hyperinsulinemic hypoglycemia without exogenous administration of insulin or its secretagogues. In adults, most cases (approximately 90%) are secondary to a single insulinoma. Other causes include insulinoma in the context of multiple endocrine neoplasia type 1 (approximately 5% of cases) and non-insulinoma pancreatogenous hypoglycemia syndrome, which is estimated to account for 0.5–5% of all cases. Recently, an entity called insulinomatosis has been described as a novel cause of EHH in adults. The characteristic feature of insulinomatosis is the synchronous or metachronous occurrence of multiple pancreatic neuroendocrine tumors expressing exclusively insulin. While most cases arise sporadically, there is recent evidence that autosomal dominant inheritance of mutations in the v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A ( MAFA ) gene can cause a familial form of insulinomatosis. In these families, EHH is paradoxically associated with the occurrence of diabetes mellitus within the same family. This review summarizes the current clinical, biochemical, imaging and genetic knowledge of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetology and Metabolism and Center of Endocrine Tumors, University Hospital of Basel, Basel, Switzerland.
- Centre for Endocrinology, William Harvey Research Institute, Barts and London School of Medicine, Queen Mary University of London, London, United Kingdom.
- Institute of Pathology, University of Bern, Bern, Switzerland.
ORCID-Profile: Emanuel Christ, Márta Korbonits
Zitieren
APA
Christ, E., Iacovazzo, D., Korbonits, M., & Perren, A. (2023). Insulinomatosis: new aspects. Endocrine-Related Cancer, 30(6). https://doi.org/10.1530/erc-22-0327
Vancouver
Christ E, Iacovazzo D, Korbonits M, Perren A. Insulinomatosis: new aspects. Endocrine-Related Cancer. 2023;30(6). doi:10.1530/erc-22-0327
BibTeX
@article{Christ2023,
author = {Christ, Emanuel and Iacovazzo, Donato and Korbonits, Márta and Perren, Aurel},
title = {Insulinomatosis: new aspects},
journal = {Endocrine-Related Cancer},
year = {2023},
volume = {30},
number = {6},
doi = {10.1530/erc-22-0327}
}
EUVIMED